Australian TGA, U.S FDA and EMEA Collaborate On International GMP Inspections For APIs
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Australia's TGA announced Jan. 12 that it had joined forces with U.S. FDA and the European Medicines Agency to conduct a pilot project collaborating on international inspections of active pharmaceutical ingredient manufacturers in third-country locations
You may also be interested in...
U.S. FDA’s International Offices To Be Fully Staffed By End Of Summer
By the end of the summer, U.S. FDA will have a permanent staff in its newly opened international offices in China, Europe, India and Latin America
U.S. FDA’s International Offices To Be Fully Staffed By End Of Summer
By the end of the summer, U.S. FDA will have a permanent staff in its newly opened international offices in China, Europe, India and Latin America
FDA’s International Offices To Be Fully Staffed By End Of Summer
Agency sought out only senior, internal employees for the job, noting it needed people it could trust in China and India.